1-Methylhistamine - CAS 501-75-7
Catalog: |
BB026939 |
Product Name: |
1-Methylhistamine |
CAS: |
501-75-7 |
Synonyms: |
2-(1-methyl-4-imidazolyl)ethanamine; 2-(1-methylimidazol-4-yl)ethanamine |
Application: |
Enzyme Inhibitors |
IUPAC Name: | 2-(1-methylimidazol-4-yl)ethanamine |
Description: | 1-Methylhistamine (CAS# 501-75-7) is used in high fiber diets, promoting gluconeogenesis and inhibit glycolysis in muscle. |
Molecular Weight: | 125.17 |
Molecular Formula: | C6H11N3 |
Canonical SMILES: | CN1C=C(N=C1)CCN |
InChI: | InChI=1S/C6H11N3/c1-9-4-6(2-3-7)8-5-9/h4-5H,2-3,7H2,1H3 |
InChI Key: | FHQDWPCFSJMNCT-UHFFFAOYSA-N |
Boiling Point: | 296.7 °C at 760 mmHg |
Purity: | > 95 % |
Density: | 1.11 g/cm3 |
Appearance: | Solid |
LogP: | 2.22560 |
GHS Hazard Statement: | H314 (100%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation] |
Precautionary Statement: | P260, P261, P264, P271, P272, P280, P285, P301+P330+P331, P302+P352, P303+P361+P353, P304+P340, P304+P341, P305+P351+P338, P310, P312, P321, P333+P313, P342+P311, P363, P403+P233, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
CN-111599476-A | Hypertension prediction model and establishment method thereof and biomarker for predicting hypertension | 20200515 |
WO-2021195577-A2 | Compositions for modulating gut microflora populations, enhancing drug potency and treating viral infections, and methods for making and using same | 20200326 |
CN-113214289-A | 5-HT2A receptor antagonists and their use for the treatment of central nervous system disorders | 20200121 |
WO-2021147818-A1 | 5-ht2a receptor antagonist and application thereof in treating central nervous system diseases | 20200121 |
WO-2021090748-A1 | Nitrile-group-containing copolymer rubber | 20191105 |
PMID | Publication Date | Title | Journal |
22652469 | 20121101 | Urinary excretion of histamine and methylhistamine after burns | Burns : journal of the International Society for Burn Injuries |
23024426 | 20121001 | Inability to replicate cerebrospinal fluid histamine deficits in the primary hypersomnias: a back to the drawing board moment | Sleep |
23024434 | 20121001 | Normal cerebrospinal fluid histamine and tele-methylhistamine levels in hypersomnia conditions | Sleep |
22435702 | 20120501 | Tryptase and histamine metabolites as diagnostic indicators of indolent systemic mastocytosis without skin lesions | Allergy |
22229787 | 20120301 | High prevalence of fractures and osteoporosis in patients with indolent systemic mastocytosis | Allergy |
Complexity: | 84.4 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 125.095297364 |
Formal Charge: | 0 |
Heavy Atom Count: | 9 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 125.095297364 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 43.8 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | -0.6 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Amines and Anilines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS